Persistence Capital Partners acquires Access Genomics

Persistence Capital Partners acquired Access Genomics, a life science company in Ontario, Canada.

Deal at a glance

TargetAccess Genomics Buyer Persistence Capital Partners SectorLife Science LocationOntario, Canada ValueNot disclosed

Target company

Access Genomics

Ontario, Canada

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

Persistence Capital Partners

Private equity firm · 21 deals on record

21deals, all time

2in this sector

2020latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Repare Therapeutics, Inc.Same sector and country · Jan 2026

LSK Technologies, Inc.Same sector and country · May 2022

A&L Canada Laboratories, Inc.Same sector and country · May 2022

Questions about this deal

Who acquired Access Genomics?Persistence Capital Partners acquired Access Genomics.

What type of deal was it?It was a transaction in the life science sector.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).